These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2499418

  • 41. Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.
    Bernacki RJ, Bansal SK, Gurtoo HL.
    Cancer Res; 1987 Feb 01; 47(3):799-802. PubMed ID: 3100025
    [Abstract] [Full Text] [Related]

  • 42. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro.
    McGown AT, Fox BW.
    Cancer Chemother Pharmacol; 1986 Feb 01; 17(3):223-6. PubMed ID: 3742706
    [Abstract] [Full Text] [Related]

  • 43. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
    Jardine I, Fenselau C, Appler M, Kan MN, Brundrett RB, Colvin M.
    Cancer Res; 1978 Feb 01; 38(2):408-15. PubMed ID: 620410
    [Abstract] [Full Text] [Related]

  • 44. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury.
    Kachel DL, Martin WJ.
    J Pharmacol Exp Ther; 1994 Jan 01; 268(1):42-6. PubMed ID: 8301583
    [Abstract] [Full Text] [Related]

  • 45. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
    Powers JF, Sladek NE.
    Cancer Res; 1983 Mar 01; 43(3):1101-6. PubMed ID: 6825082
    [No Abstract] [Full Text] [Related]

  • 46. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
    Pendyala L, Creaven PJ, Schwartz G, Meropol NJ, Bolanowska-Higdon W, Zdanowicz J, Murphy M, Perez R.
    Clin Cancer Res; 2000 Apr 01; 6(4):1314-21. PubMed ID: 10778956
    [Abstract] [Full Text] [Related]

  • 47. The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
    Momerency G, Van Cauwenberghe K, Slee PH, Van Oosterom AT, De Bruijn EA.
    Biol Mass Spectrom; 1994 Mar 01; 23(3):149-58. PubMed ID: 8148406
    [Abstract] [Full Text] [Related]

  • 48. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF.
    Cancer Res; 1982 Aug 01; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract] [Full Text] [Related]

  • 49. Role of Fenton chemistry in thiol-induced toxicity and apoptosis.
    Held KD, Sylvester FC, Hopcia KL, Biaglow JE.
    Radiat Res; 1996 May 01; 145(5):542-53. PubMed ID: 8619019
    [Abstract] [Full Text] [Related]

  • 50. Possible role of acrolein in 4-hydroperoxycyclophosphamide-induced cell damage in vitro.
    Blomgren H, Hallström M.
    Methods Find Exp Clin Pharmacol; 1991 May 01; 13(1):11-4. PubMed ID: 1908032
    [Abstract] [Full Text] [Related]

  • 51. Quantification by gas chromatography of N,N'-di-(2-chloroethyl)-phosphorodiamidic acid in the plasma of patients receiving isophosphamide.
    Bryant BM, Jarman M, Baker MH, Smith IE, Smyth JF.
    Cancer Res; 1980 Dec 01; 40(12):4734-8. PubMed ID: 7438105
    [Abstract] [Full Text] [Related]

  • 52. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
    Struck RF, Alberts DS.
    Cancer Treat Rep; 1984 May 01; 68(5):765-70. PubMed ID: 6722832
    [Abstract] [Full Text] [Related]

  • 53. The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactions.
    Shulman-Roskes EM, Noe DA, Gamcsik MP, Marlow AL, Hilton J, Hausheer FH, Colvin OM, Ludeman SM.
    J Med Chem; 1998 Feb 12; 41(4):515-29. PubMed ID: 9484502
    [Abstract] [Full Text] [Related]

  • 54. Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity.
    Bacherikov VA, Chou TC, Dong HJ, Zhang X, Chen CH, Lin YW, Tsai TJ, Lee RZ, Liu LF, Su TL.
    Bioorg Med Chem; 2005 Jun 02; 13(12):3993-4006. PubMed ID: 15911312
    [Abstract] [Full Text] [Related]

  • 55. Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.
    Cox PJ, Phillips BJ, Thomas P.
    Cancer Treat Rep; 1976 Apr 02; 60(4):321-6. PubMed ID: 179712
    [Abstract] [Full Text] [Related]

  • 56. Modeling H-bonding and solvent effects in the alkylation of pyrimidine bases by a prototype quinone methide: a DFT study.
    Freccero M, Di Valentin C, Sarzi-Amadè M, DFT study.
    J Am Chem Soc; 2003 Mar 26; 125(12):3544-53. PubMed ID: 12643716
    [Abstract] [Full Text] [Related]

  • 57. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.
    Fleer R, Brendel M.
    Chem Biol Interact; 1982 Mar 01; 39(1):1-15. PubMed ID: 7037214
    [Abstract] [Full Text] [Related]

  • 58. Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth-inhibitory activity in human breast cancer cells.
    Roth T, Tang W, Eisenbrand G.
    Anticancer Drug Des; 1995 Dec 01; 10(8):655-66. PubMed ID: 8595124
    [Abstract] [Full Text] [Related]

  • 59. Protonation of phosphoramide mustard and other phosphoramides.
    Gamcsik MP, Ludeman SM, Shulman-Roskes EM, McLennan IJ, Colvin ME, Colvin OM.
    J Med Chem; 1993 Nov 12; 36(23):3636-45. PubMed ID: 8246232
    [Abstract] [Full Text] [Related]

  • 60. Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.
    Pendyala L, Schwartz G, Smith P, Zdanowicz J, Murphy M, Hausheer F.
    Cancer Chemother Pharmacol; 2003 May 12; 51(5):376-84. PubMed ID: 12682786
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.